Under construction – not a live service
Sign in
Taking peopleNo phase

The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 18 years old?

Source: NCT07176767, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Lena Xiao
Trial code
NCT07176767
Record updated
23 September 2025
Original description
Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep.Read full original descriptionShow less

Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep.

Studying how insomnia affects PAP adherence in children can help improve future treatments.

However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.

Inclusion: Children aged 8-18 years old; Obstructive apnea-hypopnea index ≥ 5/hour on baseline diagnostic polysomnogram (PSG); Newly prescribed PAP therapy.

Exclusion: Developmental disability precluding ability to answer questionnaires.

ClinicalTrials.gov NCT07176767